Avivagen Inc VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc > Sales agreements terminated

<< Previous

Bullboard Posts

Next >>

Comment by FIRSTGMANon Oct 06, 2021 2:27pm

154 Views

Post# 33974428

RE:RE:RE:RE:RE:Sales agreements terminated

Listened to the webcast and thought the info was quite encouraging, although huge results may not come as fast as wanted. The agreement with AB VISTA seems well thought out, and have left lots of wiggle room for VIV to work with other programs, without over commitment to AB VISTA.

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement